Omnicell Inc. (OMCL)
31.35
-0.26 (-0.82%)
At close: Apr 15, 2025, 3:59 PM
32.28
2.97%
After-hours: Apr 15, 2025, 05:31 PM EDT
-0.82% (1D)
| Bid | 28 |
| Market Cap | 1.47B |
| Revenue (ttm) | 1.11B |
| Net Income (ttm) | 12.53M |
| EPS (ttm) | 0.27 |
| PE Ratio (ttm) | 116.11 |
| Forward PE | 24.79 |
| Analyst | Hold |
| Ask | 34 |
| Volume | 251,396 |
| Avg. Volume (20D) | 625,109.1 |
| Open | 31.35 |
| Previous Close | 31.61 |
| Day's Range | 30.98 - 31.95 |
| 52-Week Range | 25.12 - 55.75 |
| Beta | 0.79 |
About OMCL
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital,...
Sector Healthcare
IPO Date Aug 9, 2001
Employees 3,670
Stock Exchange NASDAQ
Ticker Symbol OMCL
Website https://www.omnicell.com
Analyst Forecast
According to 6 analyst ratings, the average rating for OMCL stock is "Hold." The 12-month stock price forecast is $52, which is an increase of 65.87% from the latest price.
Stock ForecastsNext Earnings Release
Omnicell Inc. is scheduled to release its earnings on May 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-11.15%
Omincell shares are trading lower after the compan...
Unlock content with
Pro Subscription
4 months ago
+0.83%
Omnicell shares are trading lower after the company announced a proposed private placement of $150 million in convertible senior notes.
